Pharmacoepidemiology & Therapeutic Risk Management

August 26-30, 2020 | Germany

36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) is organized by International Society for Pharmacoepidemiology (ISPE) and will be held from Aug 26 - 30, 2020 at Estrel Berlin, Berlin, Germany.

Spotlight

The central nervous system (CNS) is exquisitely tuned for performing its many core functions, but disease and dysfunction can impede its work. Disease biomarkers are chemical signatures of pathologic processes, detection of which enables diagnosis and progression analysis from blood, cerebrospinal fluid, or tissue biopsy. Biomarkers of CNS disorders have been successfully exploited for their diagnostic and prognostic value, becoming ever more valuable in the fight against insidious diseases that invade and damage our most essential organ system.


OTHER PAST CONFERENCES

19th Annual Pharma Data Congress

September 8-9, 2022 | UK

Showcasing success in FAIR data implementation, data analytics in drug discovery, AI/ML technologies, RWE management, data storage & infrastructure, multi-omic data integration and management

Pharmaceutics and Advanced Drug Delivery Systems

September 1-2, 2022 | Italy

4th International Conference on Pharmaceutics and Advanced Drug Delivery Systems will welcome you to Rome, Italy September 1-2, 2022.

Drug Discovery And Communal Trial

August 27-28, 2022 | Malaysia

Association of Pharmaceutical Research (APR) organizes the “Pharma Summit 2022: Drug Discovery & Communal Trial” on 27th & 28th August 2022, in Kuala Lumpur, Malaysia.

80TH FIP WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

September 18-22, 2022 | Spain

At this critical time, when the challenges presented by the COVID-19 pandemic are still current and on the minds of healthcare professionals, we must take the opportunity to create more comprehensive plans to better manage health crises that may be on the horizon.

Spotlight

The central nervous system (CNS) is exquisitely tuned for performing its many core functions, but disease and dysfunction can impede its work. Disease biomarkers are chemical signatures of pathologic processes, detection of which enables diagnosis and progression analysis from blood, cerebrospinal fluid, or tissue biopsy. Biomarkers of CNS disorders have been successfully exploited for their diagnostic and prognostic value, becoming ever more valuable in the fight against insidious diseases that invade and damage our most essential organ system.

resources